The Chinese University of Hong Kong
Shatin, 999077, Hong Kong
NCT Number: NCT05548010
Venous thromboembolism (VTE) is common especially among post-operative patients, and its occurrence is associated with significant morbidity and mortality. VTE is highly preventable with prophylactic modalities ranging from conservative measures such as early mobilization, to mechanical prophylaxis such as intermittent pneumatic compression (ICP), to pharmacological prophylaxis such as peri-operative anticoagulation. Despite established guidelines from various professional societies, the practice of VTE prophylaxis varied greatly from institute to institute. Evidence suggests that there is a significant gap between the optimal thromboprophylaxis as suggested by experts and real-work practice. Many healthcare-providers (HCP) and patients at risk of VTE are either not aware of the risk of VTE or not confident to apply the necessary thromboprophylaxis. The knowledge level of VTE appears to play a key role in affecting the level of compliance to the optimal thromboprophylaxis. Considerable improvement in VTE prophylaxis utilization may result from the implementation of a multifaceted educational program. By improving patient's awareness on VTE prophylaxis, the incidence of DVT might be reduced. The knowledge level of patients can be improved by various means including educational video, administrative measures, or continue medical education program. However, no prospective study has been performed to assess the impact of an educational program on the VTE knowledge level among post-operative patients and their HCP, and if any improvement of their knowledge level can be translated to a better adherence to VTE prophylaxis guidelines. We therefore propose to conduct a prospective non-randomized controlled study to evaluate the effect of an education materials for the patients as well as their HCP on their knowledge level as well as the utilization and adherence of VTE prophylaxis in these patients by comparing two groups of patients and HCP.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Shatin, 999077, Hong Kong
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention
Time frame: 4 weeks
Difference between the knowledge level in the subject group and HCP group after the administration of the educational materials as measured with questionnaire
Time frame: 4 weeks
Difference in VTE prophylaxis prescribed by HCP after the administration of the educational materials assessed upon patient follow-up/ discharge as reflected by drug prescription sheet and discharge summary
Time frame: 4 weeks
VTE prophylaxis will be advised to subjects upon discharge. Difference in VTE prophylaxis adherence of subjects after the administration of the educational materials will be assessed verbally during follow-up consultation by investigators.
Time frame: 4 weeks
difference in VTE knowledge level within the HCP group before and after the administration of the educational materials as measured with questionnaire.
Time frame: 4 weeks
Difference in patient satisfaction scoring before and after the administration of the educational materials to the HCPs assessed during patient follow-up consultation by investigators
Time frame: 4 weeks
Difference in rate of VTE in the HCP group before and after the administration of the educational materials.
Chinese University of Hong Kong
Other
Evaluation of a Short Educational Materials in Improving the Knowledge Level of Venous Thromboembolism and the Compliance of Thromboprophylaxis in Post-operative Patients: a Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04616846
COVID-19, Cardiovascular Diseases
Cagnes-sur-Mer, Alpes-Maritimes, France
View Trial DetailsNCT05643885
Cardiovascular Diseases, Embolism and Thrombosis
New York, United States
View Trial DetailsNCT06118957
Cardiovascular Diseases, Embolism and Thrombosis
Salt Lake City, Utah, United States
View Trial DetailsNCT05625932
Cardiovascular Diseases, Colonic Diseases
Santiago de Compostela, A Coruña, Spain
View Trial Details